Neuro Biomarkers of Smoking Behavior
Study Description
“Neuro Biomarkers of Smoking Behavior”
The purpose of this study is to evaluate cognition in smokers and nonsmokers. It involves administration of intranasal insulin (Novolin R), an investigational medication followed by a brief non-invasive cognitive test, during which brain waves are recorded. All participants will receive both Novolin R and placebo in two separate testing sessions.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - Novolin R
Novolin R is a sterile, clear, aqueous, and colorless solution that contains human insulin (rDNA origin) 100 units/mL, glycerol 16 mg/mL, metacresol 3 mg/mL, zinc chloride approximately 7 mcg/mL and water for injection. The pH (potential Hydrogen) is adjusted to 7.4. Hydrochloric acid 2N (concentration) or sodium hydroxide 2N may be added to adjust pH. Novolin R vials are latex-free. The drug substance is being purchased from McKesson.
Additional Information
Official Study Title
Neurologic Biomarkers of Smoking Behavior
Clinical Trial ID
NCT03811951
ParticipAid ID
bkRBYa
